| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.83 | 0.0008 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.21 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |